SR
Shenzhen Readline Biotech Co., Ltd
Manufacturer · Shenzhen, China
Overview
Shenzhen Readline Biotech uses an AI and synthetic-biology platform to make active ingredients, including cosmetic peptides, NAD+, NMN, ergothioneine and semaglutide, with production in Gansu and Zhuhai and a UK R&D centre. Its lead biopharma product is semaglutide raw material, and its test centre has CNAS accreditation. It holds active US Type II DMFs covering semaglutide, its main chain and its side chain.
Capabilities
- Synthetic-biology manufacturing
- Semaglutide intermediates
- Cosmetic peptides
- Nutrition ingredients
Quality signals
| GMP evidence | Not found |
|---|---|
| Certificates of analysis | Not found |
| Third-party testing | Not found |
| ISO certification | Not found |
| Makes own product | Yes, in-house production |